Antimicrobial Resistance Mechanisms and Antimicrobial Resistance Genes of Pathogens, 2nd Edition

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".

Deadline for manuscript submissions: closed (15 November 2024) | Viewed by 222

Special Issue Editors


E-Mail
Guest Editor
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
Interests: microbial genetics and genomics; antimicrobial resistance; nanotechnology
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
Interests: microbial genetics and genomics; antimicrobial resistance

Special Issue Information

Dear Colleagues,

The first edition of the Special Issue “Antimicrobial Resistance Mechanisms and Antimicrobial Resistance Genes of Pathogens” was published in 2023: https://www.mdpi.com/journal/antibiotics/special_issues/resistance_genes_antibiotics.

It is a successful collection with nine excellent papers and has encouraged us to open a second edition with the same topic. As a continuation of the first Special Issue, this second edition aims to seek manuscript submissions that offer insights into the surveillance, epidemiology, biochemistry, genetics and genomics of antimicrobial resistance genes and associated mobile genetic elements.

Prof. Dr. Dongsheng Zhou
Dr. Zhe Yin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug resistance
  • genomic epidemiology
  • mobile genetic elements

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop